Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats

Chinese Journal of Physiology

Volumn 55, Issue 3, 2012, Pages 192-201

  Chang, Chih Chun ^a   Chang, Chieh Yu ^a   Huang, Jiung Pang ^a   Hung, Li Man ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Inflammation; Liver; Oxidative stress; Resveratrol; Spleen; Type 1 diabetes mellitus

Indexed keywords

3 NITROTYROSINE; ADVANCED OXIDATION PROTEIN PRODUCT; CARBONYL DERIVATIVE; CHOLESTEROL; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; RESVERATROL; SUPEROXIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HEPATITIS; HYPERINSULINEMIA; HYPERINSULINEMIC ACTIVITY; HYPOCHOLESTEROLEMIC ACTIVITY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIVER; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SPLEEN; STREPTOZOCIN DIABETES; ANIMAL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; LONG EVANS RAT; METABOLISM;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; LIVER; OXIDATIVE STRESS; RATS; RATS, LONG-EVANS; SPLEEN; STREPTOZOCIN;

EID: 84861434958     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2012.BAA012     Document Type: Article

References (27)

1. Ates, O., Cayli, S.R., Yucel, N., Altinoz, E., Kocak, A., Durak, M.A., Turkoz, Y. and Yologlu, S. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J. Clin. Neurosci. 14: 256-260, 2007.
2. Ceriello, A. Oxidative stress and glycemic regulation. Metabolism 49: 27-29, 2000.
3. Cheng, H.M., Hsiang, C.Y., Chen, G.W., Wu, S.L., Chen, J.C., Huang, C.Y., Bau, D.T. and Ho, T.Y. Inhibition of lipopolysaccharide-induced interleukin-1β and tumor necrosis factor-α production by menthone through nuclear factor-κB signaling pathway in HaCat cells. Chinese. J. Physiol. 51: 160-166, 2008.
4. Cignarella, A., Minici, C., Bolego, C., Pinna, C., Sanvito, P., Gaion, R.M. and Puglisi, L. Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr.Metab. Cardiovasc. Dis. 16: 322-329, 2006.
5. de la Lastra, C.A. and Villegas, I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49: 405-430, 2005.
6. de la Lastra, C.A. and Villegas, I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 35: 1156-1160, 2007.
7. Dirks Naylor, A.J. Cellular effects of resveratrol in skeletal muscle. Life Sci. 84: 637-640, 2009.
8. Evans, J.L., Goldfine, I.D., Maddux, B.A. and Grodsky, G.M. Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes. Endocr. Rev. 23: 599-622, 2002.
9. Gonzales, A.M. and Orlando, R.A. Curcumin and resveratrol inhibit nuclear factor-κB-mediated cytokine expression in adipocytes. Nutr. Metab. (Lond). 5: 17, 2008.
10. Hernández Marco, R., Oxidant/antioxidant status and hyperfiltration in young patients with type 1 diabetes mellitus. Pediatr. Nephrol. 24: 121-127, 2009.
11. Huang, J.P., Huang, S.S., Deng, J.Y., Chang, C.C., Day, Y.J. and Hung, L.M. Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin. Free Radic. Biol. Med. 49: 1710-1721, 2010.
12. Khan, M.M., Ishrat, T., Ahmad, A., Hoda, M.N., Khan, M.B., Khuwaja, G., Srivastava, P., Raza, S.S., Islam, F. and Ahmad, S. Sesamin attenuates behavioral, biochemical and histological alterations induced by reversible middle cerebral artery occlusion in the rats. Chem. Biol. Interact. 183: 255-263, 2010.
13. Klinge, C.M., Blankenship, K.A., Risinger, K.E., Bhatnagar, S., Noisin, E.L., Sumanasekera, W.K., Zhao, L., Brey, D.M. and Keynton, R.S. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors α and β in endothelial cells, J. Biol. Chem. 280: 7460-7468, 2005.
14. Manna, P., Das, J., Ghosh, J. and Sil, P.C. Contribution of type 1 diabetes to rat liver dysfunction and cellular damage via activation of NOS, PARP, IkappaBalpha/NF-kappaB, MAPKs, and mitochondria-dependent pathways: Prophylactic role of arjunolic acid. Free Radic. Biol. Med. 48: 1465-1484, 2010.
15. Manna, S.K., Mukhopadhyay, A. and Aggarwal, B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164: 6509-6519, 2000.
16. Mohamed, A.K., Bierhaus, A., Schiekofer, S., Tritschler, H., Ziegler, R. and Nawroth, P.P. The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10: 157-167, 1999.
17. Palsamy, P. and Subramanian, S. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed. Pharmacother. 62: 598-605, 2008.
18. Palsamy, P., Sivakumar, S. and Subramanian, S. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats. Chem. Biol. Interact. 186: 200-210, 2010.
19. Palsamy, P. and Subramanian, S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J. Cell. Physiol.224: 423-432, 2010.
20. Sharma, S., Anjaneyulu, M., Kulkarni, S.K. and Chopra, K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76: 69-75, 2006.
21. Su, H.C., Hung, L.M. and Chen, J.K. Resveratrol, a red wineantioxidant, possesses an insulin-like effect in streptozotocininduced diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290: 1339-1346, 2006.
22. Thirunavukkarasu, M., Penumathsa, S.V., Srikanth, K., Juhasz, B., Zhan, L., Otani, H., Bagchi, D., Das, D.K. and Maulik, N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin and heme oxygenase. Free Radic. Biol. Med. 43: 720-729, 2007.
23. Uchida, Y., Yamazaki, H., Watanabe, S., Hayakawa, K., Meng, Y., Hiramatsu, N., Kasai, A., Yamauchi, K., Yao, J. and Kitamura, M. Enhancement of NF-κB activity by resveratrol in cytokine-exposed mesangial cells. Clin. Exp. Immunol. 142: 76-83, 2005.
24. Ungvari, Z., Labinskyy, N., Mukhopadhyay, P., Pinto, J.T., Bagi, Z., Ballabh, P., Zhang, C., Pacher, P. and Csiszar, A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am. J. Physiol. Heart. Circ. Physiol. 297: H1876-H1881, 2009.
25. Zhang, H., Zhang, J., Ungvari, Z. and Zhang, C. Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 29: 1164-1171, 2009.
26. Zimmerman, M.A. and Flores, S.C. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes. J. Surg. Res. 155: 173-178, 2009.
27. Zivić S., Vlaski, J., Kocić G., Pesić M., Cirić V. and Durić Z. The importance of oxidative stress in pathogenesis of type 1 diabetes-determination of catalase activity in lymphocytes of diabetic patients. Med. Pregl. 61: 458-463, 2008.